 |
Melvyn Rubenfire is a cardiologist in the University of Michigan Health System, as well as a professor in the department of internal medicine. He is also director of the preventive cardiology department.
|
Melvyn Rubenfire is a cardiologist in the University of Michigan Health System, as well as a professor in the department of internal medicine. He is also director of the preventive cardiology department.
Rubenfire's clinical and research interests include: Atherosclerosis detection, preventive cardiology, lipid management, pulmonary hypertension, coronary risk factors and vascular reactivity.
Rubenfire earned a Doctor of Medicine degree from Wayne State University in Detroit, Michigan, in 1965. He served his residency in internal medicine at Sinai Hospital in Detroit, Michigan, from 1965–1968. [1] He then served two fellowships (1968-1970) in cardiovascular disease at the Henry Ford Hospital in Detroit, Michigan.
He received certifications in internal medicine in 1965, cardiovascular disease in 1973, and medical examination in 1965. He also received a qualification in lipid management in 2005. [1] Rubenfire holds the following fellowships: Fellow of the American College of Physicians (Internal Medicine), Fellow of the American College of Cardiology, and Fellow of the American College of Chest Physicians.
From 1970 to 1989 he was the Chief of Cardiology at Detroit's Sinai Hospital, becoming Chairman of the Department of Internal Medicine in 1984. At the same time he served as an assistant professor (1971-1976), associate professor (1977-1984), and professor (1984-1991) at Wayne State University. [2]
In 1991 Rubenfire came to the University of Michigan as a professor. He is the director of the university's Cardiac Rehabilitation, Preventive Cardiology, and Lipid Management programs. [2] He currently works at the University of Michigan Health System's Cardiovascular Medicine outpatient facility at Domino's Farms Office Park in Ann Arbor, Michigan, [3] and the Alfred Taubman Health Care Center. At Domino's Farms, he practices preventive cardiology, cardiac rehabilitation and the Cardiovascular Executive Health Program. He practices pulmonary hypertension at the Alfred Taubman Health Care Center.
The University of Michigan has raised funds to establish a Melvyn Rubenfire Professorship in Preventive Cardiology. [2]
Cardiology is the study of the heart. Cardiology is a branch of medicine that deals with disorders of the heart and the cardiovascular system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists, a specialty of internal medicine. Pediatric cardiologists are pediatricians who specialize in cardiology. Physicians who specialize in cardiac surgery are called cardiothoracic surgeons or cardiac surgeons, a specialty of general surgery.
The University of Ottawa Heart Institute (UOHI) (French: Institut de cardiologie de l'Université d'Ottawa ) is Canada's largest cardiovascular health centre. It is located in Ottawa, Ontario, Canada. It began as a department in The Ottawa Hospital, and since has evolved into Canada's only complete cardiac centre, encompassing prevention, diagnosis, treatment, rehabilitation, research, and education.
Michigan Medicine is the academic medical center of the University of Michigan, a public research university in Ann Arbor, Michigan.
Paul N. Yu was an American cardiologist, physician-scientist and educator of Chinese descent, and a product of Chinese, British and American medical education. Over a career spanning several decades he trained numerous individuals in clinical cardiology who went on to leadership positions in academia throughout this country.
Michael Lesch was a Jewish American physician and medical educator who helped identify an important genetic disorder associated with retardation and self-mutilation. This disease is now known as the Lesch–Nyhan syndrome. In the mid-1960s when the syndrome was discovered, Lesch was a research associate working at the Laboratory of General and Comparative Biochemistry at the NIH National Institute of Mental Health in Bethesda, Maryland. William Nyhan, a pediatrician and biochemical geneticist, was his mentor. Lesch was 30 years old when he discovered the disease.
Cardiac disease in China is on the rise. Though incidences of heart disease have increased faster in the city than in the countryside, rural morbidity and mortality rates are now on the rise as well. Health statistics shows that the ischemic heart disease mortality rate in rural China has approximately doubled since 1988.
Sean Patrick Pinney is an American cardiologist and the Director of both the Advanced Heart Failure and Cardiac Transplant Program and the Pulmonary Hypertension Program at Mount Sinai Medical Center in New York City.
Mary Ann McLaughlin is an American cardiologist, the author of multiple book chapters and an associate professor at Mount Sinai Medical Center in New York City.
Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.
Barry A. Love is an American cardiologist specializing in pediatric and congenital heart problems.
Jeremiah Stamler was an American scientist specializing in preventive cardiology and the study of the influence of various risk factors on coronary heart disease and other cardiovascular diseases, and the role of salt and other nutrients in the etiology of hypertension and coronary heart disease. Stamler is credited with introducing the term "risk factors" into the field of cardiology. In 1988, he was awarded the Donald Reid Medal given by the London School of Hygiene and Tropical Medicine for his contributions to epidemiology. He was professor emeritus of preventive medicine at Northwestern University in Chicago, Illinois. After his retirement from active teaching, he continued his research with his wife Rose until her death in 1998; in his later years he divided his time between Manhattan, Long Island, Chicago, and Pioppi in Southern Italy.
Richard Starr Ross was an American cardiologist and served as Dean of Johns Hopkins University's School of Medicine from 1975 to 1990. He examined Richard M. Nixon for the Watergate investigation.
Thomas G. Pickering was a British physician and academic. He was a professor of medicine at College of Physicians and Surgeons, Columbia University Medical Center in New York City. He was an internationally renowned expert in clinical hypertension and a leader in the fields of hypertension and cardiovascular behavioral medicine. He coined the term "white-coat hypertension" to describe those whose blood pressure was elevated in the doctor's office, but normal in everyday life. He later published the first editorial describing "masked hypertension". He also discovered and gave his name to the Pickering Syndrome, where bilateral renal artery stenosis causes flash pulmonary edema.
Gerald Sanders Berenson was an American cardiologist, heart researcher, and public health specialist who specialized in researching the causes of heart diseases. Berenson's fundamental research revealed that adult heart disease arises from practices and behaviors that begin in childhood. He also discovered that atherosclerosis was significantly more pronounced in individuals who had three or four cardiovascular risk factors compared to those who had none.
Richard Stanley Cooper is an American cardiologist and epidemiologist who is Chair of the Department of Public Health Sciences at Loyola University Chicago's Stritch School of Medicine. He is known for researching hypertension and other cardiac diseases in individuals of African ancestry.
Shelby Kutty is an Indian-born American cardiologist, a professor of pediatrics and internal medicine at the Johns Hopkins University School of Medicine. He holds the Helen B. Taussig endowed professorship at Johns Hopkins and is Director of the Helen B. Taussig Heart Center at the Johns Hopkins Hospital. Prior to this, he held the title of assistant dean for research and development and vice chair of pediatrics at the University of Nebraska Medical Center College of Medicine.
Dr. Robert S. Rosenson is a Professor of Medicine and also lending his services as the Director of cardio metabolic disorders at the Icahn School of Medicine at Mount Sinai.
Partho P. Sengupta is an Indian-American cardiologist. He is the Henry Rutgers Professor of Cardiology and Chief of the Division of Cardiovascular Disease & Hypertension at the Robert Wood Johnson Medical School (RWJMS) and the Chief of Cardiology, Robert Wood Johnson University Hospital (RWJUH) since July 1, 2021. Between 2019 and 2021, Dr. Sengupta was the Abnash C. Jain Chair & Professor of Cardiology at West Virginia University School of Medicine and the Chief of Division of Cardiology, Chair of Cardiovascular Innovation and Director of Cardiac Imaging at West Virginia University Heart and Vascular Institute.
Jason C. Kovacic is an Australian-born cardiologist and physician-scientist; the Robert Graham Chair and Professor of Medicine, University of New South Wales; Executive Director of the Victor Chang Cardiac Research Institute in Sydney, Australia; and Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, New York.
Sanjay Rajagopalan is the Herman Hellerstein Professor of Medicine and Chief Scientific and Medical Officer at the Harrington Heart and Vascular Institute, University Hospitals and Professor Medicine at Case Western Reserve University (CWRU) in Cleveland, Ohio. He holds secondary appointments in the Case Western Reserve University Departments of Physiology, Radiology and Biomedical Engineering. Much of his research has been on using technology to guide the detection and treatment of heart disease and more recently on the impact of environmental exposures and climate change on cardiovascular health.
